iifl-logo

Avience Biomedicals Ltd Share Price Live

Add as a Preferred Source on Google
277.75
(-4.39%)
Jul 10, 2026|09:20:01 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open301.1
  • Day's High307
  • 52 Wk High414.95
  • Prev. Close290.5
  • Day's Low275
  • 52 Wk Low 276.4
  • Turnover (lac)184.98
  • P/E31.54
  • Face Value10
  • Book Value0
  • EPS9.21
  • Mkt. Cap (Cr.)152.35
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Avience Biomedicals Ltd KEY RATIOS

Sector

Healthcare

Open

₹301.1

Prev. Close

₹290.5

Turnover(Lac.)

₹184.98

Day's High

₹307

Day's Low

₹275

52 Week's High

₹414.95

52 Week's Low

₹276.4

Book Value

₹0

Face Value

₹10

Mkt Cap (₹ Cr.)

152.35

P/E

31.54

EPS

9.21

Divi. Yield

0

Avience Biomedicals Ltd Corporate Action

No Record Found

Avience Biomedicals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Avience Biomedicals Ltd SHAREHOLDING SNAPSHOT

12 Jul, 2026|11:14 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 87.88%

Foreign: 0.00%

Indian: 87.88%

Non-Promoter- 12.11%

Institutions: 12.11%

Non-Institutions: 0.00%

Custodian: 0.00%

Share PriceShare Price

Avience Biomedicals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

4.03

3.28

3.28

2.03

Preference Capital

0

0

0

0

Reserves

16.37

2.78

0.79

0.76

Net Worth

20.4

6.06

4.07

2.79

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024

Gross Sales

41.84

45.24

23.96

Excise Duty

0

0

0

Net Sales

41.84

45.24

23.96

Other Operating Income

0

0

0

Other Income

0.11

0.73

0.41

Avience Biomedicals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

8,841

84.681,27,127.92382.40.232,438.5692.92

Max Healthcare Institute Ltd

MAXHEALTH

1,108.1

147.951,07,850.01203.210.18732.991.84

Fortis Healthcare Ltd

FORTIS

968

358.5473,083.7224.980.1460.73122.24

Aster DM Healthcare Ltd

ASTERDM

808.9

127.741,882.3127.460.37655.183.23

Narayana Hrudayalaya Ltd

NH

2,027.3

77.0641,417.8202.130.221,044.05127.1

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Avience Biomedicals Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / Managing Director

Dharam Deo Choudhary

E D & Wholetime Director

Ram Nagina Choudhary

Executive Director

Deepa Choudhary

Non Executive Director

Janardan Pal

Independent Non Exe. Director

Om Prakash Pal

Independent Non Exe. Director

Pankaj Sharma

Company Sec. & Compli. Officer

MANOJ KUMAR

Registered Office

C-11 Block-C Community Cemtre,

Janakpuri A-3,

Delhi - 110058

Tel: 1800-12-04-636

Website: http://www.avienbio.com

Email: info@avienbio.com

Registrar Office

D-153/A 1st Flr,

Okhla Industrial Are, Phase-I,

New Delhi-110020

Tel: 011 - 26812682 / 83

Website: www.skylinerta.com

Email: admin@skylinerta.com

Summary

Avience Biomedicals Limited was originally incorporated as Private Limited Company as Avience Biomedicals Private Limited on December 23, 2019 with the Registrar of Companies, Delhi. Later, Companys s...
Read More

Company FAQs

What is the Avience Biomedicals Ltd share price today?

The Avience Biomedicals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹277.75 today.

What is the Market Cap of Avience Biomedicals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Avience Biomedicals Ltd is ₹152.35 Cr. as of 10 Jul ‘26

What is the PE and PB ratio of Avience Biomedicals Ltd?

The PE and PB ratios of Avience Biomedicals Ltd is 31.54 and 2.01 as of 10 Jul ‘26

What is the 52 Week High and Low of Avience Biomedicals Ltd?

The 52-week high/low is the highest and lowest price at which a Avience Biomedicals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Avience Biomedicals Ltd is ₹276.4 and ₹414.95 as of 10 Jul ‘26

What is the CAGR of Avience Biomedicals Ltd?

Avience Biomedicals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at -29.99%.

What is the shareholding pattern of Avience Biomedicals Ltd?

The shareholding pattern of Avience Biomedicals Ltd is as follows:
Promoters - 64.59 %
Institutions - 12.15 %
Public - 23.26 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.